#hmp3

2g or 1g? We review a recent study on the use of Tranexamic Acid (TXA) in traumatic brain injury (TBI) patients with intracranial hemorrhage (ICH), focusing on prehospital care. The study, a subgroup analysis from the Prehospital TXA for TBI Trial, comp

Background The use of TXA in traumatic brain injury has been debated since early studies like CRASH-2, which found that TXA could reduce mortality in bleeding trauma patients. Subsequent trials, including CRASH-3, examined its potential benefits specifically for TBI patients, showing mixed results. While CRASH-3 found no overall survival benefit, it did suggest a decrease in mortality for…

Our conference report from 11th Kongress der Arbeitsgemeinschaft fur Notfallmedizin @stemlyns Blog themes on trauma, cardiac arrest and research . #FOAMed

This month I was in Graz, Austria at the 11th Kongress der Arbeitsgemeinschaft fur Notfallmedizin. Although EM is not a primary speciality in Austria it is very clear that there are many clinicians who are interested in emergency care. There is always an English only track and so I would defo recommend a trip out here if you want to learn about EM in a wider Europe and without a focus on the…

A great review of day 2 of the London Trauma Conference with Zaf Qasim @resusone Loads to learn and a must attend in 2023 #FOAMed @stemlyns @karimbrohi @lauraoc25 @traumameic @obidoc @psirides @LDN_TC #LTC2022

Despite the socializing and “Stand-Up Science” events that ran pretty late into the night, there was no holding back the full cohort of attendees for Day 2 of LTC. Let’s see what this day offered: Neurosurgeon Aminul Ahmed began the day with an interesting review of the role of stem cells in head injury. Traumatic brain injury (TBI) remains a continuing challenge to trauma clinicians from…

Part 1 review of the 2022 London Trauma Conference with Zaf @resusone #FOAMed @stemlyns #ltc2022 @LDN_TC @karimbrohi @kinabamd @mikeabernathy @appearce2 @rebecca_rigney @rossdavenport

I’ll admit I was very excited and honored to receive the invite to speak in-person at the London Trauma Conference. I’d had the pleasure of speaking there in 2019, and that was my last international conference prior to the pandemic being declared. Following two years of primarily virtual conferences (with their inherent pros and cons), I was ready to challenged and educated by my fellow speakers.…

Hypocalcaemia, Trauma and Major Transfusion at @stemlyns via @docib Also check our @emcrit on same. #FOAMed for all.

I’m writing this blog post after listening to the ever excellent Scott Weingart on the EMCrit podcast in discussion with the authors of this paper, to which I highly recommend you listen. Why bother to write about hypocalcaemia on St Emlyn’s when it’s already in the FOAMed forum I hear you ask. Well, I thought it would be worth considering in the UK context (as well as getting the discussion…

Top 10 trauma papers 2019-2020 for Liverpool Trauma Seminars. St Emlyn's #FOAMed @stemlyns @traumaliverpool @simonjudemerce

This week I am presenting (virtually) at the Liverpool Trauma Seminar. This is a new initiative that aims to provide a multispeciality, multidisciplinary trauma conference in the North West of England. It’s run out of Aintree hospital, a level 1 trauma centre, with support from a wider variety of organisations.

[cite]

The plan was to have a two day conference this week, but COVID-19…

JC: AVP in Haemorrhagic Shock. St Emlyn's Should we use Arginine Vasopressin in trauma patients? With @doccjf #FOAMed #trauma #JC @stemlyns

Blood product transfusion can be lifesaving for patients who have suffered major trauma, but the associated side-effects and risks, mean that most people would agree that less is more. This paper by Sim et al examines whether giving arginine vasopressin (AVP) can reduce blood product requirements in patients receiving massive transfusions following trauma. 

Effect of Low-Dose Supplementation of…

JC: Can we really use IO blood for analysis? St Emlyn's #FOAMed #dogmalysis Does anyone actually do this in practice? IO usually rejected here. Evidence very poor in critically ill patients

For as long as I can remember I’ve been told that it is possible to analyse marrow from an intra-osseous (IO) needle. It’s been taught on lots of APLS courses I’ve attended (Ed – in other words you’ve taught it!), but can it really work? There are many recommendations suggesting good correlation, but those who have read the evidence have suggested that the data in critically unwell patients may…